/PRNewswire/ - Atlas Corp. ("Atlas" or the "Company") (NYSE: ATCO) announced today its results for the quarter ended December 31, 2022. Financial Highlights:.
Daniel Dae Kim's smile lit up the room on Friday at the Riverhorse on Main Street in Park City, where Sunrise Collective will host its Sunrise House over opening weekend — offering interactive daytime programming and events that br.
Monoclonal antibodies that millions of Americans rely on to treat the coronavirus are rapidly losing their healing power, forcing researchers around the world to devise new antibodies that are more potent and more resistant to new variants.
Lab-made therapies are rapidly losing their healing power, forcing researchers around the world to devise new antibodies that are both more potent and more resistant to new variants.